Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular AMD (nAMD) that
accounts for a significant proportion of nAMD cases worldwide, and particularly in Asia …

We evaluated the efficacy and safety of loading phase treatment with intravitreal
brolucizumab for neovascular age-related macular degeneration (nAMD) with type 1 …

Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular age-related macular
degeneration (nAMD), commonly seen in the Asian population. It is dissimilar in …

Purpose To investigate the efficacy and safety of loading phase treatment with 3 monthly
intravitreal injections of faricimab for neovascular age-related macular degeneration …

Purpose To evaluate the effects of aflibercept therapy using a treat-and-extend regimen on
treatment-naïve polypoidal choroidal vasculopathy (PCV). Methods In a retrospective …

Introduction: The purpose of this study was to evaluate the outcomes of loading-phase
treatment with intravitreal aflibercept (IVA) or brolucizumab (IVBr) for treatment-naïve …

Polypoidal choroidal vasculopathy (PCV) is a vascular disease of the choroid that leads to
hemorrhagic and exudative macular degeneration. It may cause significant vision loss and …

Purpose To investigate the clinical features, treatment options, and visual outcomes of
submacular hemorrhage (SMH) secondary to neovascular age-related macular …

Polypoidal choroidal vasculopathy (PCV) is a disease characterized by subretinal pigment
epithelium (RPE) orange-red polypoidal lesions and abnormal branching neovascular …

Purpose To compare the efficacy of photodynamic therapy (PDT) in eyes with polypoidal
choroidal vasculopathy (PCV) associated with and without pachychoroid phenotypes …